U.Y. Fincorp Q2 FY26: PAT up 133%, revenue down 39%

Revenue DeclinePat Growth 25pctResults View source PDF Explain this filing

UYFINCORP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.1%Reaction day

₹16.00

prior close

₹16.18

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%+3.5% vs market

Non Banking Financial Company (NBFC) peers, median of 202sector-0.0%+3.2% vs sector

On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 3.2 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.5

15m

+1.4

30m

+5.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.1-0.4+3.5-0.0+3.2

Next day

+1.3-0.6+1.9-0.4+1.7

+0.0+0.3-0.3-0.0+0.0

+1.9+0.2+1.7-0.1+2.0

-1.6+0.1-1.7+0.1-1.6

-4.4+0.7-5.1-0.2-4.1

-5.0-0.3-4.7-1.4-3.6

15d

-6.9-2.0-4.9-2.7-4.1

-9.4-5.7-3.7-5.7-3.7

-14.2-7.8-6.4-6.7-7.4

-5.7-4.6-1.1-9.0+3.3

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 202Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

U.Y. Fincorp posted Q2 FY26 standalone profit of Rs 809.32 lakh, up 133% from Rs 346.57 lakh in Q2 FY25. Half-year PAT grew 64% to Rs 1,406.06 lakh. Total income fell sharply. Q2 income dropped 39% to Rs 2,765.69 lakh and H1 income fell 39% to Rs 4,997.66 lakh, mainly due to lower sale of shares. Interest income rose and impairment provisions reversed, boosting profit. EPS for H1 stood at Rs 0.74. The board approved the reviewed results on 7 November 2025.

Likely market impact

Profit jumped on impairment reversals and lower trading activity, but revenue fell 39% YoY. Strong short-term earnings contrast with a weaker top line.